Lerchenmueller, Marc J.
Schmallenbach, Leo http://orcid.org/0000-0001-5302-2578
Bley, Maximilian http://orcid.org/0000-0003-3019-8727
Lerchenmüller, Carolin http://orcid.org/0000-0002-5620-0285
Funding for this research was provided by:
Dr. Hans Riegel Foundation
Dr. Hans Riegel Foundation, Herz Foundation
Article History
Received: 15 November 2022
Accepted: 20 June 2023
First Online: 17 July 2023
Competing interests
: M.J.L. is a co-founder and shareholder of AaviGen GmbH, a cardiovascular gene therapy company, which is unrelated to this article. The remaining authors have no competing interests.